Emerging Markets

Latin America

With offices in Argentina, Mexico and Brazil as well as legal entities in Chile and Peru, PRA can provide full-service capabilities and clinical trial coverage anywhere within Latin America and the Caribbean.

Regional Advantages: Latin America

• Established presence in a region with a growing population of 600 million spread across 21 countries
• 74% of the population lives in Brazil, Mexico, Colombia and Argentina
• Access to treatment-naïve patients in many different indications
• Higher compliance and retention rates among clinical trial patients
• Similar disease profile to North America and Europe, with complicated diseases such as hepatitis, tissue infection and HIV; age-related chronic diseases such as cancer, diabetes, and rheumatoid arthritis; tropical diseases; and infectious diseases
• Medical professionals receive training locally as well as in the EU and United States, and are knowledgeable of ICH GCP guidelines

PRA in Latin America has the expertise, experience and investigator relationships that you need to run a successful clinical trial in the region.

For more information on how PRA can make your next Latin America trial a success, please contact us via email at endpoints@praintl.com.